What Clinical Events Count Toward an APS Diagnosis?
At a Glance
An APS diagnosis usually combines persistent antiphospholipid antibodies, confirmed on tests at least 12 weeks apart, with an objectively confirmed blood clot or a specific pregnancy complication. Doctors consider your history because research criteria are not rigid clinical rules.
In this answer
3 sections
When doctors evaluate you for antiphospholipid syndrome (APS), they look for two main things: persistently positive blood tests for antiphospholipid antibodies and at least one qualifying clinical event [1]. Historically, the main clinical events have fallen into two categories: objectively confirmed blood clots (thrombosis) and specific patterns of pregnancy complications [1][2].
It is important to understand that the strict lists of events—such as the classic Sapporo/Sydney criteria—were designed primarily to classify patients for research studies, not as rigid rules for clinical diagnosis [3].
A Note on “Persistently Positive” Blood Tests
An APS diagnosis requires a persistent immune response. This means testing positive for at least one of three specific antibodies: lupus anticoagulant (LA), anticardiolipin (aCL), or anti-beta-2-glycoprotein I (anti-β2GPI) [3]. Because infections or acute illness can cause temporary positives, the test must be positive on two separate occasions at least 12 weeks apart [4][5]. Additionally, being on blood thinners can interfere with lupus anticoagulant testing, so your doctor will need to interpret these results carefully [6]. Having a family history of APS is a risk factor but does not replace the need for positive blood tests or a clinical event [7].
Vascular Events (Blood Clots)
To qualify as a classic APS event under the Sapporo/Sydney criteria, a blood clot must meet specific requirements:
- Objectively confirmed: The clot must be proven through imaging (such as an ultrasound showing a deep vein thrombosis or a CT scan showing a pulmonary embolism) or by examining tissue samples under a microscope [1].
- No significant inflammation: If diagnosed via tissue sample, the pathology report must show a clot without significant inflammation of the blood vessel wall [8][9].
- Location: The clot can occur in veins (like in your leg), arteries (like in a stroke), or small blood vessels (microvascular) in any organ or tissue [1].
- Alternative causes: If a clot happens after surgery, during prolonged bed rest, or while taking estrogen, it might still satisfy the definition of a documented clot. However, your doctor will carefully consider whether the clot was truly caused by APS or by the other risk factors [10][11]. Having another inherited clotting disorder does not automatically prove or rule out APS.
Pregnancy Complications
Because APS can affect the placenta and its blood flow, specific pregnancy complications also count as qualifying events [2]. Under the classic criteria, these include:
- Late fetal loss: One or more unexplained deaths of a morphologically normal (structurally typical) fetus at or beyond the 10th week of pregnancy [2].
- Premature delivery: One or more deliveries of a morphologically normal baby before 34 weeks of pregnancy, specifically caused by severe preeclampsia, eclampsia, or placental insufficiency (when the placenta cannot provide enough oxygen and nutrients to the baby) [2][12].
- Recurrent early miscarriages: Three or more consecutive, spontaneous miscarriages occurring before the 10th week of pregnancy. For these to count, other explanations—such as maternal anatomical or hormonal issues, and parental chromosomal abnormalities—must be ruled out [2][13]. A single or two early miscarriages do not meet this specific threshold.
Classification Criteria vs. Clinical Diagnosis
The criteria described above (the Sapporo/Sydney criteria) rely on a simple checklist. Recently, researchers developed the newer 2023 ACR/EULAR criteria, which use a weighted point system that scores your specific lab results and clinical events (including heart valve disease and low platelets) to determine if you can be classified as having APS for research studies [3].
However, neither the classic nor the 2023 criteria are mandatory rules for how your doctor treats you in real life. In clinical practice, your doctor will look at the entire picture [14][15]. A doctor may still diagnose and manage your care if your specific experience does not perfectly match the strict research criteria, though a positive antibody test or a symptom alone (without a qualifying event) does not automatically establish an APS diagnosis [16]. They will evaluate your complete medical and obstetric history, the timing of events, imaging results, and bleeding risks to determine the best treatment plan for you.
Common questions in this guide
What types of blood clots count as an APS clinical event?
Which pregnancy complications can count toward APS?
How do antiphospholipid antibody tests support an APS diagnosis?
Can a positive APS antibody test alone diagnose APS?
Do the Sapporo/Sydney or 2023 ACR/EULAR criteria decide whether I have APS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do my past blood clots or pregnancy complications meet the formal clinical criteria for an APS diagnosis?
- 2.What imaging, pathology, or pregnancy records do we need to gather to objectively confirm my past events?
- 3.How do my other risk factors for blood clots or pregnancy loss affect how we interpret my history?
- 4.Which specific antiphospholipid antibodies tested positive, and have they been confirmed at least 12 weeks apart?
- 5.If I don't perfectly meet the strict research criteria, how does that change your approach to my diagnosis and treatment?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.
Sciascia S, Amigo MC, Roccatello D, Khamashta M
Nature reviews. Rheumatology 2017; (13(9)):548-560 doi:10.1038/nrrheum.2017.124.
PMID: 28769114 - 2
Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes.
Žigon P, Perdan Pirkmajer K, Tomšič M, et al.
Journal of immunology research 2015; (2015()):975704 doi:10.1155/2015/975704.
PMID: 26078985 - 3
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Barbhaiya M, Zuily S, Naden R, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(10)):1687-1702 doi:10.1002/art.42624.
PMID: 37635643 - 4
An advanced understanding of the heterogeneous clinical features of "non-criteria" obstetric antiphospholipid syndrome: Two case reports and a literature review.
Peng X, Tan X, Xing A
Frontiers in immunology 2023; (14()):1122127 doi:10.3389/fimmu.2023.1122127.
PMID: 36865564 - 5
Obstetric antiphospholipid syndrome.
Antovic A, Sennström M, Bremme K, Svenungsson E
Lupus science & medicine 2018; (5(1)):e000197 doi:10.1136/lupus-2016-000197.
PMID: 30364418 - 6
Testing for the lupus anticoagulant: the good, the bad, and the ugly.
Favaloro EJ, Pasalic L, Selby R
Research and practice in thrombosis and haemostasis 2024; (8(3)):102385 doi:10.1016/j.rpth.2024.102385.
PMID: 38623474 - 7
New ACR/EULAR 2023 classification criteria for antiphospholipid syndrome, what should a gynaecologist know in 2025.
Murarasu A, de Frémont GM, Guettrot-Imbert G, et al.
Journal of gynecology obstetrics and human reproduction 2026; (55(2)):103095 doi:10.1016/j.jogoh.2025.103095.
PMID: 41422861 - 8
Catastrophic antiphospholipid syndrome of pregnancy with acute massive cerebral infarction: A case report.
Hu X, Liu M
Medicine 2024; (103(50)):e40829 doi:10.1097/MD.0000000000040829.
PMID: 39686499 - 9
Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report.
Barbhaiya M, Taghavi M, Zuily S, et al.
The Journal of rheumatology 2024; (51(2)):150-159 doi:10.3899/jrheum.2022-1200.
PMID: 37399462 - 10
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only.
Pengo V, Sarti L, Poli D, et al.
Seminars in thrombosis and hemostasis 2026; (52(6)):741-745 doi:10.1055/a-2731-2213.
PMID: 41151783 - 11
[Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
Gao R, Qin L
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2024; (55(3)):513-520 doi:10.12182/20240560104.
PMID: 38948301 - 12
Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients.
Larosa M, Le Guern V, Morel N, et al.
Arthritis research & therapy 2021; (23(1)):134 doi:10.1186/s13075-021-02518-7.
PMID: 33947469 - 13
Anti-phospholipid antibodies and reproductive failures.
Beltagy A, Trespidi L, Gerosa M, et al.
American journal of reproductive immunology (New York, N.Y. : 1989) 2021; (85(4)):e13258 doi:10.1111/aji.13258.
PMID: 32347616 - 14
The Performance of 2023 American College of Rheumatology (ACR) / European Alliance of Associations for Rheumatology (EULAR) Antiphospholipid Syndrome Classification Criteria in a Real-World Rheumatology Department.
Usta A, Yayla ME, Uslu E, et al.
Mediterranean journal of hematology and infectious diseases 2024; (16(1)):e2024074 doi:10.4084/MJHID.2024.074.
PMID: 39534708 - 15
Impact of the 2023 ACR/EULAR Classification Criteria in Women with Primary Antiphospholipid Syndrome during Pregnancy.
Martínez-Taboada VM, Gómez AM, Del Barrio-Longarela S, et al.
Diagnostics (Basel, Switzerland) 2024; (14(19)) doi:10.3390/diagnostics14192162.
PMID: 39410566 - 16
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains.
Barbhaiya M, Zuily S, Amigo MC, et al.
Current rheumatology reports 2025; (27(1)):41 doi:10.1007/s11926-025-01202-y.
PMID: 41296194
This page is for informational purposes only and does not provide medical advice. A hematology or obstetric clinician should interpret your antibody results, clot records, and pregnancy history to determine how APS criteria apply to you.
Get notified when new evidence is published on familial antiphospholipid syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.